European Medical Solutions
ALEMS.BR · BRU
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 21.09 | -0.22 | 0.02 | -0.06 |
| FCF Yield | -0.13% | -2.74% | -4.40% | -13.96% |
| EV / EBITDA | 54.57 | 93.86 | -48.98 | 35.83 |
| Quality | ||||
| ROIC | 1.12% | 1.44% | -3.33% | 3.00% |
| Gross Margin | 33.71% | 39.30% | 61.37% | 40.04% |
| Cash Conversion Ratio | 8.91 | 2.53 | 0.21 | -2.73 |
| Growth | ||||
| Revenue 3-Year CAGR | 283.13% | 287.02% | 248.48% | 223.79% |
| Free Cash Flow Growth | 96.64% | 35.16% | 54.43% | -1,730.88% |
| Safety | ||||
| Net Debt / EBITDA | 21.33 | 28.81 | -13.96 | 12.97 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 1.26 | 1.06 | 1.00 | 0.93 |
| Cash Conversion Cycle | 46.76 | 50.35 | 95.07 | 76.17 |